Covaxin Delhi

Administering of precaution dose of COVID-19 vaccines began in Delhi on Sunday amid a steady rise in daily case count in the last few days here, even as the pace was sluggish with a few private vaccination centres starting the exercise.

Private hospitals in Tamil Nadu have not slashed the prices of Covid vaccines -- Covishield ad Covaxin -- even though the government has announced a massive reduction.

The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.

The Delhi High Court today sought response of the centre on a plea by a cancer patient seeking permission to take Covaxin as the second dose of vaccine as advised by the doctors, instead of Covishield which was administered to him as the first dose

The stock of Coronavirus vaccine in the national capital will last for another eight days, according to a vaccination bulletin issued by the Delhi government today.

With 2,77,870 doses left in Delhi's Covid vaccine bank on Monday morning, the vaccine stock will last for less than a day, according to a bulletin issued by the city government.

Bharat Biotech's Covaxin is being tested on children as young as two years old. The results of these trials will be known in two-to-three months, AIIMS Delhi chief Dr Randeep Guleria has said.

Covid vaccination centres catering to the 18 years-and-above age group in Delhi were expected to shut down today but for the arrival of over 2.3 lakh doses, which included both Covaxin and Covishield.

The Delhi government has been at loggerheads with the Centre of supplies of Covid vaccines. Now the state has received over 1.2 lakh of Covishield and 20,000 additional doses of Covaxin.

The 'delta' variant of COVID-19 - the version first detected in India in October last year - is capable of infecting people even after they have received both doses of the Covaxin or Covishield vaccines, according to studies by AIIMS and the NCDC

The youth of Delhi is now travelling 100 km to get vaccinated as it has been two weeks since the stock of Covishield and Covaxin vaccines depleted in the national capital for the 18-44 age group, AAP leader and MLA Atishi said on Sunday.

Covaxin in Delhi will be administered only to those in the 18-44 age group who need the second dose, the Delhi government said in a statement on Sunday.

The screening of children for clinical trials of Covaxin will start at AIIMS in Delhi from today, days after similar trials started at AIIMS in Patna, sources have said.

The Delhi government told the Delhi High Court on Friday that it made preparations for vaccinating people with Covaxin based on its manufacturer Bharat Biotech's assurance.

A plea has been moved in the Delhi High Court seeking stay on the phase II/III clinical trials of Covaxin - Bharat Biotech's Covid Vaccine - on 2-18 year olds.

Administering of precaution dose of COVID-19 vaccines began in Delhi on Sunday amid a steady rise in daily case count in the last few days here, even as the pace was sluggish with a few private vaccination centres starting the exercise.

Private hospitals in Tamil Nadu have not slashed the prices of Covid vaccines -- Covishield ad Covaxin -- even though the government has announced a massive reduction.

The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.

The Delhi High Court today sought response of the centre on a plea by a cancer patient seeking permission to take Covaxin as the second dose of vaccine as advised by the doctors, instead of Covishield which was administered to him as the first dose

The stock of Coronavirus vaccine in the national capital will last for another eight days, according to a vaccination bulletin issued by the Delhi government today.

With 2,77,870 doses left in Delhi's Covid vaccine bank on Monday morning, the vaccine stock will last for less than a day, according to a bulletin issued by the city government.

Bharat Biotech's Covaxin is being tested on children as young as two years old. The results of these trials will be known in two-to-three months, AIIMS Delhi chief Dr Randeep Guleria has said.

Covid vaccination centres catering to the 18 years-and-above age group in Delhi were expected to shut down today but for the arrival of over 2.3 lakh doses, which included both Covaxin and Covishield.

The Delhi government has been at loggerheads with the Centre of supplies of Covid vaccines. Now the state has received over 1.2 lakh of Covishield and 20,000 additional doses of Covaxin.

The 'delta' variant of COVID-19 - the version first detected in India in October last year - is capable of infecting people even after they have received both doses of the Covaxin or Covishield vaccines, according to studies by AIIMS and the NCDC

The youth of Delhi is now travelling 100 km to get vaccinated as it has been two weeks since the stock of Covishield and Covaxin vaccines depleted in the national capital for the 18-44 age group, AAP leader and MLA Atishi said on Sunday.

Covaxin in Delhi will be administered only to those in the 18-44 age group who need the second dose, the Delhi government said in a statement on Sunday.

The screening of children for clinical trials of Covaxin will start at AIIMS in Delhi from today, days after similar trials started at AIIMS in Patna, sources have said.

The Delhi government told the Delhi High Court on Friday that it made preparations for vaccinating people with Covaxin based on its manufacturer Bharat Biotech's assurance.

A plea has been moved in the Delhi High Court seeking stay on the phase II/III clinical trials of Covaxin - Bharat Biotech's Covid Vaccine - on 2-18 year olds.